Cargando…

Overexpression of lncRNA EGFR AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non small cell lung cancer

Detalles Bibliográficos
Autores principales: Xu, Yu-Hua, Tu, Jian-Ren, Zhao, Tian-Tian, Xie, Shi-Guang, Tang, Sheng-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561623/
https://www.ncbi.nlm.nih.gov/pubmed/30664200
http://dx.doi.org/10.3892/ijo.2019.4686
_version_ 1783426165525970944
author Xu, Yu-Hua
Tu, Jian-Ren
Zhao, Tian-Tian
Xie, Shi-Guang
Tang, Sheng-Bo
author_facet Xu, Yu-Hua
Tu, Jian-Ren
Zhao, Tian-Tian
Xie, Shi-Guang
Tang, Sheng-Bo
author_sort Xu, Yu-Hua
collection PubMed
description
format Online
Article
Text
id pubmed-6561623
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-65616232019-06-26 Overexpression of lncRNA EGFR AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non small cell lung cancer Xu, Yu-Hua Tu, Jian-Ren Zhao, Tian-Tian Xie, Shi-Guang Tang, Sheng-Bo Int J Oncol Corrigendum D.A. Spandidos 2019-01-14 /pmc/articles/PMC6561623/ /pubmed/30664200 http://dx.doi.org/10.3892/ijo.2019.4686 Text en Copyright: © Xu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Corrigendum
Xu, Yu-Hua
Tu, Jian-Ren
Zhao, Tian-Tian
Xie, Shi-Guang
Tang, Sheng-Bo
Overexpression of lncRNA EGFR AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non small cell lung cancer
title Overexpression of lncRNA EGFR AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non small cell lung cancer
title_full Overexpression of lncRNA EGFR AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non small cell lung cancer
title_fullStr Overexpression of lncRNA EGFR AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non small cell lung cancer
title_full_unstemmed Overexpression of lncRNA EGFR AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non small cell lung cancer
title_short Overexpression of lncRNA EGFR AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non small cell lung cancer
title_sort overexpression of lncrna egfr as1 is associated with a poor prognosis and promotes chemotherapy resistance in non small cell lung cancer
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561623/
https://www.ncbi.nlm.nih.gov/pubmed/30664200
http://dx.doi.org/10.3892/ijo.2019.4686
work_keys_str_mv AT xuyuhua overexpressionoflncrnaegfras1isassociatedwithapoorprognosisandpromoteschemotherapyresistanceinnonsmallcelllungcancer
AT tujianren overexpressionoflncrnaegfras1isassociatedwithapoorprognosisandpromoteschemotherapyresistanceinnonsmallcelllungcancer
AT zhaotiantian overexpressionoflncrnaegfras1isassociatedwithapoorprognosisandpromoteschemotherapyresistanceinnonsmallcelllungcancer
AT xieshiguang overexpressionoflncrnaegfras1isassociatedwithapoorprognosisandpromoteschemotherapyresistanceinnonsmallcelllungcancer
AT tangshengbo overexpressionoflncrnaegfras1isassociatedwithapoorprognosisandpromoteschemotherapyresistanceinnonsmallcelllungcancer